ASX Equity Snapshot
CHM Weekly Equity Report
Chimeric Therapeutics Limited
What the company does
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing …
What the weekly tape is saying
CHM closed the latest completed week at 0.07 AUD. The 4-week return is -42.3% and the 12-week return is -62.5%. Trend Signal is inactive, Market Dynamics is -0.93. Setup signature: Risk-first tape with a 6/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.20 AUD
- Vs Trend Line
- -62.9%
- Fair Value
- 1.37 AUD
- Vs Fair Value
- -94.5%
- 52W High
- 0.60 AUD
- 52W Low
- 0.07 AUD
- Drawdown
- -87.5%
- Range Position
- 0.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- AU Healthcare
- Sector Rank
- 118 of 146
- Sector Percentile
- 19.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AU Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.4%
- Avg 4W
- -3.6%
- Trend Breadth
- 15.0%
- Positive MD
- 39.0%
AU Biotechnology
- Tracked Peers
- 47
- 4W Rank
- 47 of 47
- Avg 1W
- -0.1%
- Avg 4W
- -5.8%
- Trend Breadth
- 10.6%
- Positive RS
- 21.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.93
- 4W MD Change
- -761.1%
- Relative Strength
- -71.52
- 4W RS Change
- -31.9%
- Expectation
- Negative
- Probability
- 26.82%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 575.4K
- 13W Average
- 660.0K
- 52W Average
- 448.2K
- Vs 13W
- 0.9x
- Vs 52W
- 1.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.5%
- 52W Volatility
- 15.9%
- Upside Weeks
- 10
- Downside Weeks
- 15
- Downside Breadth
- 28.8%
- Avg Gain / Loss
- 21.5% / -20.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- ASX
- Country
- AU
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- AUD
- Market Cap
- 5.2M
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.07 AUD | -8.5% | 0.20 AUD | 1.37 AUD | -0.93 | -71.52 | 575.4K | Off |
| 5 Jun 2026 | 0.08 AUD | -18.0% | 0.21 AUD | 1.39 AUD | -0.72 | -68.98 | 2.1M | Off |
| 29 May 2026 | 0.10 AUD | -23.1% | 0.22 AUD | 1.42 AUD | -0.48 | -63.75 | 809.4K | Off |
| 22 May 2026 | 0.13 AUD | 0.0% | 0.22 AUD | 1.44 AUD | -0.03 | -53.49 | 673.4K | Off |
| 15 May 2026 | 0.13 AUD | -3.7% | 0.23 AUD | 1.46 AUD | 0.14 | -54.24 | 679.2K | Off |
| 8 May 2026 | 0.14 AUD | -18.2% | 0.23 AUD | 1.49 AUD | 0.53 | -55.21 | 1.4M | Off |
| 1 May 2026 | 0.17 AUD | 10.0% | 0.24 AUD | 1.51 AUD | 0.73 | -46.52 | 1.5M | Off |
| 24 Apr 2026 | 0.15 AUD | -25.0% | 0.25 AUD | 1.55 AUD | 0.59 | -53.07 | 279.7K | Off |
| 17 Apr 2026 | 0.20 AUD | 0.0% | 0.25 AUD | 1.59 AUD | 0.48 | -40.00 | 49.6K | Off |
| 10 Apr 2026 | 0.20 AUD | 0.0% | 0.26 AUD | 1.63 AUD | 0.10 | -41.35 | 102.8K | Off |
| 3 Apr 2026 | 0.20 AUD | 0.0% | 0.26 AUD | 1.67 AUD | -0.20 | -40.05 | 136.2K | Off |
| 27 Mar 2026 | 0.20 AUD | 0.0% | 0.26 AUD | 1.72 AUD | -0.26 | -40.45 | 101.4K | Off |
| 20 Mar 2026 | 0.20 AUD | 0.0% | 0.27 AUD | 1.75 AUD | -0.25 | -40.96 | 157.7K | Off |
| 13 Mar 2026 | 0.20 AUD | 0.0% | 0.27 AUD | 1.79 AUD | -0.07 | -43.32 | 160.5K | Off |